Fingerprint
Dive into the research topics of 'Avapritinib versus regorafenib in locally advanced unresectable or metastatic GI stromal tumor: A randomized, open-label phase III study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically